---
figid: PMC4833573__nihms738901f2
figlink: /pmc/articles/PMC4833573/figure/F2/
number: F2
caption: LGGs arise from mutations in genes whose protein products regulate RAS pathway
  signaling. In this manner, mutations in genes encoding receptor tyrosine kinases
  (RTK), which transduce extracellular signals, as well as the downstream effectors
  PTPN11, RAS, BRAF/RAF, and lead to hyperactivation of mitogenic signaling downstream
  through the MAP kinase and PI3-kinase pathways. In addition, mutational inactivation
  of the neurofibromatosis type 1 (NF1) tumor suppressor gene results in increased
  RAS activity. MEK and AKT can shorten G1 transition through mammalian target of
  rapamycin (mTOR)-dependent and -independent signaling. The presence of stromal growth
  factors and chemokines in the tumor microenvironment transduce signals through tumor
  cell receptors and further enhance glioma growth in a paracrine fashion. Reported
  mutations are denoted in green.
pmcid: PMC4833573
papertitle: Pediatric Gliomas as Neurodevelopmental Disorders.
reftext: Suzanne J. Baker, et al. Glia. ;64(6):879-895.
pmc_ranked_result_index: '122572'
pathway_score: 0.9317555
filename: nihms738901f2.jpg
figtitle: Pediatric Gliomas as Neurodevelopmental Disorders
year: ''
organisms:
- Homo sapiens
ndex: e0ce4bf3-df08-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4833573__nihms738901f2.html
  '@type': Dataset
  description: LGGs arise from mutations in genes whose protein products regulate
    RAS pathway signaling. In this manner, mutations in genes encoding receptor tyrosine
    kinases (RTK), which transduce extracellular signals, as well as the downstream
    effectors PTPN11, RAS, BRAF/RAF, and lead to hyperactivation of mitogenic signaling
    downstream through the MAP kinase and PI3-kinase pathways. In addition, mutational
    inactivation of the neurofibromatosis type 1 (NF1) tumor suppressor gene results
    in increased RAS activity. MEK and AKT can shorten G1 transition through mammalian
    target of rapamycin (mTOR)-dependent and -independent signaling. The presence
    of stromal growth factors and chemokines in the tumor microenvironment transduce
    signals through tumor cell receptors and further enhance glioma growth in a paracrine
    fashion. Reported mutations are denoted in green.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT3
  - CDKN2A
  - FGFR1
  - NMUR1
  - MAP2K1
  - NTRK2
  - CXCL11
  - CXCL6
  - PTPN11
  - MAP2K2
  - MTOR
  - AKT1
  - PPBP
  - TP53
  - BRAF
  - CXCL9
  - CXCL5
  - AKT2
  - HRAS
  - CXCL3
  - NF1
  - CXCL2
  - PF4
  - CXCL14
  - KRAS
  - NRAS
  - CXCL12
  - CXCL1
  - CXCL8
  - CXCL13
  - CXCL10
  - Cancer
  - Lung cancer
  - Noonan syndrome
genes:
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: TP53/CDKN2A
  symbol: CDKN2A
  source: hgnc_symbol
  hgnc_symbol: CDKN2A
  entrez: '1029'
- word: (FGFR1,
  symbol: FGFR1
  source: hgnc_symbol
  hgnc_symbol: FGFR1
  entrez: '2260'
- word: GPCR
  symbol: GPC-R
  source: hgnc_alias_symbol
  hgnc_symbol: NMUR1
  entrez: '10316'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: TRKB)
  symbol: TRKB
  source: hgnc_alias_symbol
  hgnc_symbol: NTRK2
  entrez: '4915'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL11
  entrez: '6373'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL6
  entrez: '6372'
- word: PTPN11
  symbol: PTPN11
  source: hgnc_symbol
  hgnc_symbol: PTPN11
  entrez: '5781'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: mTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: PPBP
  entrez: '5473'
- word: TP53/CDKN2A
  symbol: TP53
  source: hgnc_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL9
  entrez: '4283'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL5
  entrez: '6374'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL3
  entrez: '2921'
- word: NF1
  symbol: NF1
  source: hgnc_symbol
  hgnc_symbol: NF1
  entrez: '4763'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL2
  entrez: '2920'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: PF4
  entrez: '5196'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL14
  entrez: '9547'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL12
  entrez: '6387'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL1
  entrez: '2919'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL13
  entrez: '10563'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL10
  entrez: '3627'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC4833573__F2
redirect_from: /figures/PMC4833573__F2
figtype: Figure
---
